دورية أكاديمية

Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting

التفاصيل البيبلوغرافية
العنوان: Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting
المؤلفون: Garg, Mahek, Puckett, Justin, Kamal-Bahl, Sachin, Raut, Monika, Ryland, Katherine Elizabeth, Doshi, Jalpa A., Huntington, Scott F.
المساهمون: Merck & Co Inc
المصدر: Clinical Lymphoma Myeloma and Leukemia ; ISSN 2152-2650
بيانات النشر: Elsevier BV
سنة النشر: 2024
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Cancer Research, Oncology, Hematology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.clml.2024.01.010
الإتاحة: https://doi.org/10.1016/j.clml.2024.01.010Test
https://api.elsevier.com/content/article/PII:S2152265024000545?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2152265024000545?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by/4.0Test/
رقم الانضمام: edsbas.CC259FDE
قاعدة البيانات: BASE